EMPTX Performance — UBS Emerging Markets Equity Opportunity Fund, Class P2
Data updated: 2026-09-11
EMPTX returned +25.29% year to date and +52.57% over one year to Jun 2026. Annualised returns are +24.70% over 3 years and +5.97% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $194, against $179 for the category, and to $153 over one year, against $141. Volatility over the past three years was 17.35% a year. In the 12 months to Jun 2026 the fund lost a net $110.0M, and assets reached $463.78M.
EMPTX Growth of $100
What $100 invested in UBS Emerging Markets Equity Opportunity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | EMPTX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $153 | $141 |
| 3 years (Jul 2023 – Jun 2026) | $194 | $179 |
| 5 years (Jul 2021 – Jun 2026) | $134 | $144 |
| Since data start (Jul 2019 – Jun 2026) | $187 | $195 |
EMPTX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +25.29% |
| 1 year | +52.57% |
| 3 years (annualised) | +24.70% |
| 5 years (annualised) | +5.97% |
EMPTX Annual Returns
Calendar-year total returns of UBS Emerging Markets Equity Opportunity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +25.29% |
| 2025 | +43.81% |
| 2024 | +2.53% |
| 2023 | +8.93% |
| 2022 | −25.38% |
| 2021 | −9.17% |
| 2020 | +24.78% |
| 2019 (Jul–Dec) | +10.17% |
EMPTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +10.7% | +4.6% | −11.1% | +12.8% | +8.9% | −1.0% | — | — | — | — | — | — |
| 2025 | +2.3% | +2.6% | +1.4% | +0.8% | +3.6% | +6.3% | +2.0% | +3.1% | +9.1% | +4.1% | −1.9% | +4.0% |
| 2024 | −4.7% | +2.8% | +3.1% | +0.7% | +1.6% | +2.8% | −2.9% | +0.6% | +6.7% | −3.2% | −4.2% | −0.1% |
| 2023 | +9.7% | −8.1% | +1.9% | −2.3% | −1.0% | +4.4% | +5.5% | −5.8% | −3.1% | −3.2% | +9.7% | +2.6% |
| 2022 | −0.6% | −6.6% | −6.6% | −5.3% | +1.5% | −7.0% | −0.9% | −0.1% | −9.3% | −4.2% | +16.5% | −3.8% |
| 2021 | +3.3% | +0.2% | −2.8% | +1.2% | −0.1% | +0.3% | −7.6% | +2.5% | −4.0% | +1.8% | −5.7% | +1.9% |
| 2020 | −3.8% | −3.6% | −17.2% | +8.3% | +3.1% | +8.6% | +9.5% | +1.5% | −1.7% | +3.2% | +10.7% | +7.3% |
| 2019 | — | — | — | — | — | — | −2.5% | −3.1% | +2.3% | +5.4% | −0.1% | +8.2% |
EMPTX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 17.35%
- 3-year Sharpe ratio: 1.16 (vs 4.5% risk-free rate)
- Best month: +12.83% (Apr 2026)
- Worst month: −11.08% (Mar 2026)
EMPTX Fund Flows
Monthly money in and out of UBS Emerging Markets Equity Opportunity Fund, from SEC Form N-PORT.
- 12-month net flow: −$110.0M
- 12-month gross sales (incl. reinvestments): $48.6M
- Sales ÷ redemptions: 0.31×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $2.3M | $6.6M | −$4.3M |
| May 2026 | $1.7M | $5.2M | −$3.6M |
| Apr 2026 | $891K | $6.3M | −$5.4M |
| Mar 2026 | $2.4M | $5.2M | −$2.8M |
| Feb 2026 | $2.4M | $5.3M | −$2.8M |
| Jan 2026 | $7.8M | $17.3M | −$9.5M |
| Dec 2025 | $10.7M | $15.8M | −$5.1M |
| Nov 2025 | $2.3M | $5.0M | −$2.7M |
| Oct 2025 | $3.1M | $5.3M | −$2.2M |
| Sep 2025 | $4.7M | $3.4M | $1.3M |
| Aug 2025 | $4.0M | $4.4M | −$344K |
| Jul 2025 | $6.3M | $78.7M | −$72.4M |
EMPTX Assets Under Management
Net assets of UBS Emerging Markets Equity Opportunity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $463.78M |
| 2026-03-31 | $392.66M |
| 2025-12-31 | $395.09M |
| 2025-09-30 | $389.38M |
| 2025-06-30 | $408.65M |
| 2025-03-31 | $352.14M |
| 2024-12-31 | $381.80M |
| 2024-09-30 | $471.82M |
| 2024-06-30 | $458.66M |
| 2024-03-31 | $472.68M |
| 2023-12-31 | $439.44M |
| 2023-09-30 | $445.20M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.